Hospitalized Children
10
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
National Observatory of Mycoplasma Infections in Children Under 18 Ages in France
CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
Impact of Therapeutic Storytelling on Fear, Screen Time, and Parental Stress Among Hospitalized Children
Impact of Conversational Approaches in Pediatric Social Robot-Mediated Interventions
Evidence-based Practice in the Management of Gastric Tube Placement in Children
The Role of Therapy Dogs in Reducing Depression, Anxiety, and Loneliness Among Hospitalized Children
Targeted Inpatient Navigation to Improve Care for Minority Children and Families
Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children
Medical Clowning: Needs Assessment and Implication for Hospitalized Children With Cancer/Blood Disease
Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children